Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System

Conditions:   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention:   Device: vena cava filter implantation (LUMIFI with Crux VCF System)
Sponsor:   Volcano Corporation
Not yet recruiting - verified March 2015

Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

Condition:   Pulmonary Embolism
Intervention:   Device: IVC Filter
Sponsors:   New England Research Institutes;   IVC Filter Study Group Foundation (IDE Sponsor);   ALN Implants Chirurgicaux;   B. Braun Interventional Systems, Inc;   Bard Peripheral Vascular, Inc;   Cook;   Cordis Corporation;   Volcano Corporation;   Rex Medical
Not yet recruiting - verified March 2015

Comparison of Topical and Intravenous Tranexamic Acid in Total Hip Arthroplasty

Condition:   Blood Loss
Interventions:   Drug: 0.9% sodium chloride;   Drug: tranexamic  acid;   Drug: tranexamic  acid
Sponsor:   Shanghai Jiao Tong University School of Medicine
Recruiting - verified December 2014

Location of Lower Extremity Deep Vein Thrombosis by Emergency Physicians Using Portable Compression Ultrasonography

Condition:   Deep Vein Thrombosis
Interventions:   Procedure: portable venous compression ultrasonography;   Procedure: venous compress ultrasonography;   Procedure: Doppler ultrasound of the lower limbs
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified March 2015

Genotype-guided Warfarin Individualized Treatment

Conditions:   Atrial Fibrillation;   Deep Venous Thrombosis
Interventions:   Behavioral: Genotype-guided dosing algorithm for warfarin;   Behavioral: Standard initiation dose for warfarin
Sponsor:   The Third Xiangya Hospital of Central South University
Recruiting - verified October 2014

Using a Novel Algorithm to Improve the Retrieval Rate of Inferior Vena Cava Filters (iRetrieve Study)

Conditions:   Venous Thromboembolism,;   Pulmonary Embolism,;   Deep Vein Thrombosis,
Intervention:  
Sponsor:   Heart and Vascular Outcomes Research Institute
Not yet recruiting - verified March 2015

Venous Thrombectomy/Thrombolysis Outcome Registry

Conditions:   Deep Venous Thrombosis;   Post Thrombotic Syndrome
Intervention:  
Sponsor:   Heart and Vascular Outcomes Research Institute
Recruiting - verified March 2015

Cancer Venous Thromboembolism (VTE)

Conditions:   Venous Thromboembolism (VTE);   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Cancer
Interventions:   Drug: edoxaban;   Drug: Dalteparin
Sponsor:   Daiichi Sankyo Inc.
Not yet recruiting - verified March 2015

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified March 2015

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

Conditions:   Hypercortisolism;   Cushing Syndrome
Intervention:   Procedure: Adrenalectomy
Sponsors:   National Cancer Institute (NCI);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   CC-OADRIS
Recruiting - verified September 2014

The SENTRY Clinical Study

Conditions:   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention:   Device: SENTRY IVC Filter
Sponsor:   Novate Medical
Recruiting - verified March 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Phenprocoumon
Sponsor:   Bayer
Recruiting - verified March 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin
Sponsor:   Bayer
Recruiting - verified March 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Acenocoumarol
Sponsor:   Bayer
Recruiting - verified March 2015

Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication

Condition:   Venous Thrombosis
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor:   Bayer
Recruiting - verified March 2015

Feasibility Study of Geko vs. IPCs in Trauma

Conditions:   Trauma;   Venous Thromboembolism
Interventions:   Device: geko;   Device: IPCs
Sponsor:   Hamilton Health Sciences Corporation
Completed - verified March 2015

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

Conditions:   Neoplasm;   Central Venous Catheter Thrombosis
Intervention:   Drug: Rivaroxaban
Sponsor:   London Health Sciences Centre
Recruiting - verified March 2015

ARIXTRA® Adherence in SVT Patients.

Condition:   Thrombosis, Venous
Intervention:   Drug: Fondaparinux
Sponsor:   GlaxoSmithKline
Completed - verified March 2015

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Conditions:   Deep Vein Thrombosis;   Venous Thrombosis
Interventions:   Drug: edoxaban tosylate;   Drug: enoxaparin/unfractionated heparin;   Drug: warfarin
Sponsor:   Daiichi Sankyo Inc.
Completed - verified March 2015

Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum

Condition:   Venous Thromboembolic Diseases
Interventions:   Drug: Bemiparin;   Drug: Enoxaparin
Sponsor:   Hawler Medical University
Completed - verified March 2015

Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)

Condition:   Ataxia
Intervention:   Drug: Fondaparinux sodium
Sponsor:   GlaxoSmithKline
Active, not recruiting - verified March 2015

Risk-adapted Therapy for Primary Systemic (AL) Amyloidosis

Condition:   Amyloidosis
Intervention:   Drug: melphalan, thalidomide and dexamethasone
Sponsor:   FDA Office of Orphan Products Development
Completed - verified July 2011

Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)

Condition:   Ankylosing Spondylitis
Intervention:  
Sponsor:   Merck Sharp & Dohme Corp.
Active, not recruiting - verified March 2015

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

Conditions:   Fetal Demise;   Fetal Growth Restriction;   Preeclampsia;   Abruptio Placentae;   Thromboembolism
Intervention:   Drug: enoxaparin
Sponsor:   HaEmek Medical Center, Israel
Recruiting - verified March 2015

Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis

Conditions:   Thrombosis;   Heparin-induced Thrombocytopenia
Intervention:   Drug: Fondaparinux
Sponsor:   FDA Office of Orphan Products Development
Completed - verified October 2011

Get CardioSmart

You're Invited